QuickMD Names Omar Manejwala, M.D. as Chief Medical Officer
Key Highlights
- ➤QuickMD appoints Omar Manejwala, M.D. as Chief Medical Officer effective November 9, 2026
- ➤QuickMD surpasses 2 million patient visits across 44 states and D.C.
- ➤Manejwala previously served as DarioHealth (DRIO) Chief Medical Officer for more than six years
- ➤QuickMD expands focus to kratom and 7-OH dependence treatment
Expert Statements
Ryan Lissack, Chief Executive Officer of QuickMD
“Starting addiction treatment is the first step toward lasting recovery. Staying in treatment is just as important, and helping patients do that has always been central to how we approach care at QuickMD.”
Ryan Lissack, Chief Executive Officer of QuickMD
“We're at an inflection point where clinical infrastructure can significantly accelerate our growth, and Omar has built that twice at digital health companies. He's also board certified in addiction medicine, which is a rare and useful combination. As the needs of people seeking addiction treatment evolve, his experience will help us build on that foundation, reach more people, and continue improving patient outcomes.”
Dr. Omar Manejwala, Chief Medical Officer of QuickMD
“When someone is ready to seek help, getting care quickly and feeling heard can make a real difference.”
Dr. Omar Manejwala, Chief Medical Officer of QuickMD
“QuickMD has built a model that makes treatment more accessible, meeting patients where they are without judgment. I'm excited to bring my experience in clinical care and research to a team that's already making a meaningful difference, and help more people stay engaged in treatment over the long term.”
LOS ANGELES, CA / ACCESS Newswire / November 2, 2026 / QuickMD, the largest U.S. telemedicine provider of opioid use disorder care, today announced the appointment of Omar Manejwala, M.D., as Chief Medical Officer, effective November 9, 2026. A nationally recognized addiction psychiatrist with experience building and scaling clinical programs at digital health companies, Dr. Manejwala will lead QuickMD's clinical function as the company surpasses 2 million patient visits and continues to grow.
Dr. Manejwala most recently served as Chief Medical Officer at DarioHealth (Nasdaq: DRIO) for more than six years, where he expanded the company's clinical capabilities, supported its transition from direct-to-consumer care to enterprise partnerships, led the company's clinical AI strategy, and grew the research function to more than 100 published studies. From 2011 to 2020, he was SVP and Chief Medical Officer at Catasys, where he built the company's clinical model and grew its contracted clinician network across 30 states. Earlier, he served as Medical Director at Hazelden. He is also the author of Craving: Why We Can't Seem to Get Enough, a bestselling book on addiction and recovery.
Get started
Create a free account to read the full story.